{"hands_on_practices": [{"introduction": "Understanding the equilibrium dissociation constant, $K_d$, begins with its direct calculation from experimental data. This foundational exercise guides you through deriving the expression for $K_d$ from the law of mass action and applying it to a set of hypothetical equilibrium concentrations. By calculating $K_d$ and interpreting its value, you will solidify your understanding of how this constant quantifies binding affinity and dictates an immunoassay's effective dynamic range.", "problem": "In a homogeneous binding immunoassay, an antibody species $A$ binds an antigen $B$ to form a 1:1 complex $AB$. At equilibrium, the measured free concentrations are $[A] = 10$ nM, $[B] = 90$ nM, and the complex concentration is $[AB] = 40$ nM. Assume a single noncooperative binding site per $A$, negligible nonspecific binding, and ideal solution behavior. Starting from the reversible reaction $A + B \\rightleftharpoons AB$, the definition of the equilibrium dissociation constant, and the mass-action law for elementary reactions, derive an expression for the equilibrium dissociation constant $K_{d}$ in terms of $[A]$, $[B]$, and $[AB]$, then evaluate $K_{d}$ numerically in nanomolar units using the given data. Finally, based on the derived occupancy relation for a 1:1 binding isotherm, interpret whether this affinity is low, moderate, or high in the context of assay sensitivity, and explain where the assayâ€™s dynamic range is expected to be centered. Express the final numerical value of $K_{d}$ in nM. No rounding requirement is imposed; report the exact computed value.", "solution": "The problem requires the derivation of the expression for the equilibrium dissociation constant, $K_d$, its numerical calculation, and an interpretation of the result in the context of immunoassay performance.\n\nThe process begins with the fundamental principles of chemical equilibrium as applied to the given bimolecular reaction. The reversible reaction between the antibody $A$ and the antigen $B$ to form the complex $AB$ is given as:\n$$\nA + B \\rightleftharpoons AB\n$$\nThis reaction is characterized by a forward (association) process and a reverse (dissociation) process. According to the law of mass action for elementary reactions, the rate of the forward reaction, $R_{fwd}$, is proportional to the product of the concentrations of the reactants, and the rate of the reverse reaction, $R_{rev}$, is proportional to the concentration of the product.\n\nLet $k_{on}$ be the association rate constant (in units of M$^{-1}$s$^{-1}$, for example) and $k_{off}$ be the dissociation rate constant (in units of s$^{-1}$). The rates are expressed as:\n$$\nR_{fwd} = k_{on}[A][B]\n$$\n$$\nR_{rev} = k_{off}[AB]\n$$\nAt chemical equilibrium, the net rate of reaction is zero, which means the rate of the forward reaction equals the rate of the reverse reaction:\n$$\nR_{fwd} = R_{rev}\n$$\nSubstituting the rate expressions gives the equilibrium condition:\n$$\nk_{on}[A][B] = k_{off}[AB]\n$$\nThe equilibrium dissociation constant, $K_d$, is defined as the ratio of the dissociation rate constant to the association rate constant:\n$$\nK_d \\equiv \\frac{k_{off}}{k_{on}}\n$$\nBy rearranging the equilibrium condition equation, we can express this ratio in terms of the equilibrium concentrations of the species involved:\n$$\n\\frac{[A][B]}{[AB]} = \\frac{k_{off}}{k_{on}}\n$$\nTherefore, the expression for the equilibrium dissociation constant $K_d$ is:\n$$\nK_d = \\frac{[A][B]}{[AB]}\n$$\nThis completes the first part of the problem.\n\nNext, we evaluate the numerical value of $K_d$ using the provided equilibrium concentrations. The given data are:\n- Free antibody concentration, $[A] = 10 \\text{ nM}$\n- Free antigen concentration, $[B] = 90 \\text{ nM}$\n- Complex concentration, $[AB] = 40 \\text{ nM}$\n\nSubstituting these values into the derived expression for $K_d$:\n$$\nK_d = \\frac{(10 \\text{ nM})(90 \\text{ nM})}{40 \\text{ nM}}\n$$\nPerforming the calculation:\n$$\nK_d = \\frac{900 \\text{ (nM)}^2}{40 \\text{ nM}} = \\frac{90}{4} \\text{ nM} = 22.5 \\text{ nM}\n$$\nThe numerical value of the equilibrium dissociation constant is $22.5$ nM.\n\nFinally, we interpret this result. The dissociation constant $K_d$ is a measure of the affinity between the antibody and the antigen. A smaller $K_d$ value indicates a higher affinity (stronger binding), while a larger $K_d$ value indicates a lower affinity (weaker binding). In the context of immunoassays:\n- High affinity is typically characterized by $K_d  1 \\text{ nM}$.\n- Moderate affinity is in the range of $K_d \\approx 1-100 \\text{ nM}$.\n- Low affinity corresponds to $K_d  100 \\text{ nM}$.\n\nThe calculated value of $K_d = 22.5 \\text{ nM}$ falls within the **moderate affinity** range. This level of affinity is common and useful for many diagnostic immunoassays.\n\nThe dynamic range of an immunoassay is the concentration range of the analyte over which the assay provides a useful and graduated response. This response is related to the fraction of antibody binding sites that are occupied by the antigen. For a single noncooperative binding site, the fractional occupancy, $\\theta$, is described by the Langmuir binding isotherm:\n$$\n\\theta = \\frac{[\\text{Bound Antibody}]}{[\\text{Total Antibody}]} = \\frac{[AB]}{[A] + [AB]}\n$$\nUsing the relationship $[A] = K_d \\frac{[AB]}{[B]}$, this can be rewritten as a function of the free antigen concentration $[B]$:\n$$\n\\theta = \\frac{[B]}{K_d + [B]}\n$$\nThis equation describes a sigmoidal relationship when plotted against $\\log([B])$. The most sensitive part of this curve, where the slope is steepest, occurs at the inflection point. The inflection point corresponds to the concentration of free antigen at which half of the total antibody binding sites are occupied ($\\theta = 0.5$). Setting $\\theta = 0.5$:\n$$\n0.5 = \\frac{[B]}{K_d + [B]} \\implies 0.5(K_d + [B]) = [B] \\implies 0.5 K_d = 0.5 [B] \\implies [B] = K_d\n$$\nThis demonstrates that the center of the assay's dynamic range, where it is most responsive to changes in analyte concentration, is located at an analyte concentration equal to the $K_d$ value. Therefore, for this particular assay, the dynamic range is expected to be centered around an antigen concentration of $22.5 \\text{ nM}$. This is the concentration at which the assay will have its greatest sensitivity for detecting changes in the amount of antigen $B$.", "answer": "$$\\boxed{22.5}$$", "id": "5113381"}, {"introduction": "Beyond calculating $K_d$, its true power lies in its predictive capacity for assay design. This practice challenges you to manipulate the standard binding isotherm to determine the precise analyte concentration needed to achieve a high level of antibody saturation. This task is not merely algebraic; it provides critical insight into the concept of saturation and why operating at the extremes of the binding curve can be impractical for quantitative measurements.", "problem": "An immunoassay uses a monoclonal antibody that binds a monovalent ligand through a reversible bimolecular interaction at equilibrium. Let the binding reaction be $A + L \\rightleftharpoons AL$, where $A$ is free antibody, $L$ is free ligand (analyte), and $AL$ is the complex. Define the equilibrium dissociation constant by $K_d = \\frac{[A][L]}{[AL]}$. The fractional occupancy of antibody binding sites is defined as $\\theta = \\frac{[AL]}{[A]_T}$, where $[A]_T$ is the total antibody site concentration. Assume independent, non-cooperative binding and that $[L]$ denotes the free ligand concentration at equilibrium.\n\nStarting only from the definitions of $K_d$ and $\\theta$, derive the expression for the free ligand concentration $[L]$ that achieves a target occupancy $\\theta$, and then use it to calculate the free ligand concentration required to achieve $\\theta = 0.9$ when $K_d = 1$ nM. Express your final numerical value for $[L]$ in nM and round to three significant figures.\n\nFinally, based on typical clinical immunoassay contexts such as Enzyme-Linked Immunosorbent Assay (ELISA), briefly comment in one or two sentences on whether operating at the calculated occupancy is generally practical in patient samples, without altering your calculated value.", "solution": "The problem requires the derivation of an expression for the free ligand concentration, $[L]$, as a function of the equilibrium dissociation constant, $K_d$, and the fractional occupancy, $\\theta$. It then asks for a numerical calculation for specific values and a brief comment on the practicality of the result in a clinical context.\n\nThe system is described by the reversible bimolecular interaction:\n$$ A + L \\rightleftharpoons AL $$\nwhere $A$ is the free antibody, $L$ is the free ligand, and $AL$ is the antibody-ligand complex.\n\nThe given definitions are:\n1.  The equilibrium dissociation constant, $K_d$:\n    $$ K_d = \\frac{[A][L]}{[AL]} $$\n2.  The fractional occupancy of antibody binding sites, $\\theta$:\n    $$ \\theta = \\frac{[AL]}{[A]_T} $$\nwhere $[A]_T$ is the total antibody site concentration.\n\nThe total concentration of antibody sites is the sum of the free sites and the occupied (bound) sites. This represents the principle of conservation of mass for the antibody.\n$$ [A]_T = [A] + [AL] $$\n\nOur goal is to derive an expression for $[L]$ in terms of $\\theta$ and $K_d$. We will start by manipulating these three fundamental equations.\n\nFirst, we express the free antibody concentration, $[A]$, in terms of the total and bound concentrations from the conservation of mass equation:\n$$ [A] = [A]_T - [AL] $$\n\nNext, we substitute this expression for $[A]$ into the definition of $K_d$:\n$$ K_d = \\frac{([A]_T - [AL])[L]}{[AL]} $$\n\nTo introduce $\\theta$ into this equation, we use its definition, $\\theta = \\frac{[AL]}{[A]_T}$. We can rearrange this to express $[AL]$ in terms of $\\theta$ and $[A]_T$:\n$$ [AL] = \\theta [A]_T $$\n\nNow, substitute this expression for $[AL]$ into our equation for $K_d$:\n$$ K_d = \\frac{([A]_T - \\theta[A]_T)[L]}{\\theta[A]_T} $$\n\nThe term $[A]_T$ appears in both the numerator and the denominator. We can factor out $[A]_T$ from the term in the parentheses:\n$$ K_d = \\frac{[A]_T(1 - \\theta)[L]}{\\theta[A]_T} $$\n\nAssuming that the total antibody concentration $[A]_T$ is non-zero (which must be true for an assay to exist), we can cancel $[A]_T$ from the numerator and denominator:\n$$ K_d = \\frac{(1 - \\theta)[L]}{\\theta} $$\n\nThis equation, commonly known as the Langmuir isotherm equation (or Hill-Langmuir equation for a Hill coefficient of $1$), relates the free ligand concentration $[L]$ to the fractional occupancy $\\theta$ and the dissociation constant $K_d$.\n\nThe final step in the derivation is to solve this equation for $[L]$:\n$$ [L] = K_d \\frac{\\theta}{1 - \\theta} $$\nThis is the desired expression for the free ligand concentration required to achieve a target occupancy $\\theta$.\n\nNow, we proceed to the numerical calculation. The problem provides the following values:\n-   Equilibrium dissociation constant, $K_d = 1$ nM.\n-   Target fractional occupancy, $\\theta = 0.9$.\n\nSubstituting these values into our derived expression:\n$$ [L] = (1 \\text{ nM}) \\times \\frac{0.9}{1 - 0.9} $$\n$$ [L] = (1 \\text{ nM}) \\times \\frac{0.9}{0.1} $$\n$$ [L] = (1 \\text{ nM}) \\times 9 $$\n$$ [L] = 9 \\text{ nM} $$\n\nThe problem asks for the answer to be rounded to three significant figures. To express $9$ with three significant figures, we write it as $9.00$.\nTherefore, the free ligand concentration required to achieve $90\\%$ occupancy is $9.00$ nM.\n\nFinally, we are asked to comment on the practicality of operating at $\\theta = 0.9$ in a clinical immunoassay context (e.g., ELISA). Operating at $90\\%$ occupancy is generally impractical for quantitative clinical immunoassays because this condition lies on the upper, saturating part of the sigmoidal dose-response curve. In this region, large changes in ligand concentration produce only small changes in signal (proportional to occupancy), leading to poor measurement sensitivity and reduced precision for distinguishing between high analyte concentrations.", "answer": "$$\\boxed{9.00}$$", "id": "5113411"}, {"introduction": "Real-world immunoassays rarely operate in an ideal environment, and specificity is a paramount concern. This advanced practice confronts the common challenge of cross-reactivity, where an interfering substance competes with the target analyte for antibody binding sites. By modeling this competitive equilibrium, you will learn to quantify the resulting measurement error and establish a rigorous, affinity-based criterion for antibody specificity, a crucial skill for validating diagnostic tests.", "problem": "A sandwich immunoassay, such as an Enzyme-Linked Immunosorbent Assay (ELISA), uses a monoclonal capture antibody that binds a target analyte $T$ and a potential cross-reactive interferent $X$. At equilibrium under monovalent binding, the distribution of capture sites among the free state and complexes with $T$ or $X$ is governed by the law of mass action and the definition of the equilibrium dissociation constant $K_d$, with $K_d = [A][L]/[AL]$ for each ligand $L$ competing for the same set of sites. Assume the detection step yields a signal proportional to the fraction of sites occupied by $T$ plus a relative contribution from sites occupied by $X$ scaled by a cross-reactive signal efficiency factor $\\beta$, where $0 \\le \\beta \\le 1$.\n\nYou are given the following assay and matrix parameters at equilibrium:\n- Target concentration $[T] = 1.0 \\,\\mathrm{nM}$.\n- Physiological interferent concentration $[X] = 1.0 \\,\\mathrm{\\mu M}$.\n- Target affinity (capture antibody for $T$): $K_{d,T} = 100 \\,\\mathrm{pM}$.\n- Interferent affinity expressed as a ratio $r \\equiv K_{d,X}/K_{d,T}$. The currently achieved ratio is $r_{\\mathrm{current}} = 1.0 \\times 10^{4}$.\n- Relative signal efficiency of $X$ when bound (compared to $T$): $\\beta = 0.050$.\n\nDefine the measured signal at equilibrium to be proportional to the sum of the fraction of capture sites occupied by $T$ plus $\\beta$ times the fraction occupied by $X$. Let $S$ denote the signal in the presence of both $T$ and $X$, and $S_{0}$ the signal in the absence of $X$ (all else equal). Define the interference in measured target signal as the relative change $I \\equiv (S - S_{0})/S_{0}$, expressed as a decimal (unitless).\n\nTasks:\n1. Starting only from the definition of $K_d$ and mass-action equilibrium for competitive binding to a single class of sites, derive an expression for $I$ in terms of $[T]$, $[X]$, $K_{d,T}$, $K_{d,X}$, and $\\beta$. Then evaluate $I$ numerically for the parameters above using $r_{\\mathrm{current}}$.\n2. Let the acceptance criterion for cross-reactivity be that the magnitude of the interference satisfies $|I| \\le I_{\\mathrm{acc}}$, with $I_{\\mathrm{acc}} = 0.050$. Derive an analytic inequality for $r$ that guarantees this criterion for the given $[T]$, $[X]$, $K_{d,T}$, and $\\beta$, and then compute the minimal $r$ that satisfies the bound.\n\nRound the threshold ratio to three significant figures. Express the final answer as the single number corresponding to the minimal acceptable ratio $r_{\\min}$ (unitless). Report only $r_{\\min}$ as your final answer.", "solution": "Let $[A]$ represent the concentration of free antibody capture sites at equilibrium. Let $[AT]$ and $[AX]$ be the concentrations of sites bound to the target analyte $T$ and the interferent $X$, respectively. The total concentration of capture sites is constant: $[A]_{\\text{total}} = [A] + [AT] + [AX]$.\n\nThe equilibrium dissociation constants for the target, $K_{d,T}$, and the interferent, $K_{d,X}$, are defined by the law of mass action:\n$$K_{d,T} = \\frac{[A][T]}{[AT]}$$\n$$K_{d,X} = \\frac{[A][X]}{[AX]}$$\nFrom these definitions, we can express the concentrations of the bound complexes in terms of the free antibody concentration:\n$$[AT] = \\frac{[A][T]}{K_{d,T}}$$\n$$[AX] = \\frac{[A][X]}{K_{d,X}}$$\nThe fractional occupancy of sites by the target, $\\theta_T$, and by the interferent, $\\theta_X$, are:\n$$\\theta_T = \\frac{[AT]}{[A]_{\\text{total}}} = \\frac{[AT]}{[A] + [AT] + [AX]}$$\n$$\\theta_X = \\frac{[AX]}{[A]_{\\text{total}}} = \\frac{[AX]}{[A] + [AT] + [AX]}$$\nSubstituting the expressions for $[AT]$ and $[AX]$ and canceling the common term $[A]$:\n$$\\theta_T = \\frac{\\frac{[T]}{K_{d,T}}}{1 + \\frac{[T]}{K_{d,T}} + \\frac{[X]}{K_{d,X}}}$$\n$$\\theta_X = \\frac{\\frac{[X]}{K_{d,X}}}{1 + \\frac{[T]}{K_{d,T}} + \\frac{[X]}{K_{d,X}}}$$\nThe measured signal, $S$, is proportional to the sum of the fraction of sites occupied by $T$ plus $\\beta$ times the fraction occupied by $X$. Let $k$ be the proportionality constant.\n$$S = k (\\theta_T + \\beta \\theta_X) = k \\left( \\frac{\\frac{[T]}{K_{d,T}} + \\beta \\frac{[X]}{K_{d,X}}}{1 + \\frac{[T]}{K_{d,T}} + \\frac{[X]}{K_{d,X}}} \\right)$$\nThe signal in the absence of the interferent, $S_0$, is obtained by setting $[X]=0$:\n$$S_0 = k \\left( \\frac{\\frac{[T]}{K_{d,T}}}{1 + \\frac{[T]}{K_{d,T}}} \\right)$$\nThe interference, $I$, is defined as $I = (S - S_0)/S_0 = S/S_0 - 1$.\n$$\\frac{S}{S_0} = \\frac{\\frac{\\frac{[T]}{K_{d,T}} + \\beta \\frac{[X]}{K_{d,X}}}{1 + \\frac{[T]}{K_{d,T}} + \\frac{[X]}{K_{d,X}}}}{\\frac{\\frac{[T]}{K_{d,T}}}{1 + \\frac{[T]}{K_{d,T}}}}$$\nTo simplify, let $u = [T]/K_{d,T}$ and $v = [X]/K_{d,X}$.\n$$I = \\frac{\\frac{u + \\beta v}{1+u+v}}{\\frac{u}{1+u}} - 1 = \\frac{(u+\\beta v)(1+u)}{u(1+u+v)} - 1$$\n$$I = \\frac{u + u^2 + \\beta v + \\beta uv - u(1+u+v)}{u(1+u+v)} = \\frac{u + u^2 + \\beta v + \\beta uv - u - u^2 - uv}{u(1+u+v)}$$\n$$I = \\frac{\\beta v + \\beta uv - uv}{u(1+u+v)} = \\frac{v(\\beta + u(\\beta-1))}{u(1+u+v)}$$\nSubstituting the original variables back, we arrive at the general expression for $I$:\n$$I = \\frac{\\frac{[X]}{K_{d,X}} \\left( \\beta + \\frac{[T]}{K_{d,T}}(\\beta - 1) \\right)}{\\frac{[T]}{K_{d,T}} \\left(1 + \\frac{[T]}{K_{d,T}} + \\frac{[X]}{K_{d,X}}\\right)}$$\n\n**Task 1: Numerical evaluation of $I$**\nWe are given:\n$[T] = 1.0 \\times 10^{-9} \\, \\mathrm{M}$\n$[X] = 1.0 \\times 10^{-6} \\, \\mathrm{M}$\n$K_{d,T} = 100 \\, \\mathrm{pM} = 1.0 \\times 10^{-10} \\, \\mathrm{M}$\n$r_{\\mathrm{current}} = K_{d,X}/K_{d,T} = 1.0 \\times 10^4$\n$\\beta = 0.050$\n\nFirst, calculate the dimensionless terms $u$ and $v$:\n$$u = \\frac{[T]}{K_{d,T}} = \\frac{1.0 \\times 10^{-9} \\, \\mathrm{M}}{1.0 \\times 10^{-10} \\, \\mathrm{M}} = 10$$\n$K_{d,X} = r_{\\mathrm{current}} \\times K_{d,T} = (1.0 \\times 10^4) \\times (1.0 \\times 10^{-10} \\, \\mathrm{M}) = 1.0 \\times 10^{-6} \\, \\mathrm{M}$\n$$v = \\frac{[X]}{K_{d,X}} = \\frac{1.0 \\times 10^{-6} \\, \\mathrm{M}}{1.0 \\times 10^{-6} \\, \\mathrm{M}} = 1$$\nNow, substitute these into the expression for $I$:\n$$I = \\frac{1 \\times (0.050 + 10(0.050-1))}{10 \\times (1 + 10 + 1)} = \\frac{0.050 + 10(-0.950)}{10 \\times 12} = \\frac{0.050 - 9.50}{120} = \\frac{-9.45}{120} = -0.07875$$\n\n**Task 2: Derivation of the minimal acceptable ratio $r_{\\min}$**\nThe acceptance criterion is $|I| \\le I_{\\mathrm{acc}}$, with $I_{\\mathrm{acc}} = 0.050$.\nAs calculated in Task 1, the term $\\beta + u(\\beta-1) = -9.45$ is negative. Since all other terms in the expression for $I$ are positive, $I$ is negative for the given parameter space. The criterion $|I| \\le I_{\\mathrm{acc}}$ thus becomes $-I \\le I_{\\mathrm{acc}}$, or $I \\ge -I_{\\mathrm{acc}}$.\n\nLet $r = K_{d,X}/K_{d,T}$ be the variable ratio. Then $K_{d,X} = r K_{d,T}$. The term $v$ becomes:\n$$v = \\frac{[X]}{K_{d,X}} = \\frac{[X]}{r K_{d,T}} = \\frac{1}{r} \\frac{[X]}{K_{d,T}}$$\nLet's define $v_0 = [X]/K_{d,T} = (1.0 \\times 10^{-6})/(1.0 \\times 10^{-10}) = 10^4$. So, $v = v_0/r$.\nThe inequality is:\n$$\\frac{\\frac{v_0}{r}(\\beta + u(\\beta-1))}{u(1+u+\\frac{v_0}{r})} \\ge -I_{\\mathrm{acc}}$$\nThe term $\\beta + u(\\beta-1)$ is negative. Let's write it as $-(u(1-\\beta)-\\beta)$.\n$$\\frac{\\frac{v_0}{r}(-(u(1-\\beta)-\\beta))}{u(1+u+\\frac{v_0}{r})} \\ge -I_{\\mathrm{acc}}$$\nMultiplying by $-1$ reverses the inequality:\n$$\\frac{\\frac{v_0}{r}(u(1-\\beta)-\\beta)}{u(1+u+\\frac{v_0}{r})} \\le I_{\\mathrm{acc}}$$\nTo clear the fraction in the denominator, multiply top and bottom by $r$:\n$$\\frac{v_0(u(1-\\beta)-\\beta)}{u(r(1+u)+v_0)} \\le I_{\\mathrm{acc}}$$\nSince all terms are positive, we can multiply by the denominator:\n$$v_0(u(1-\\beta)-\\beta) \\le I_{\\mathrm{acc}} u (r(1+u)+v_0)$$\n$$v_0(u(1-\\beta)-\\beta) \\le I_{\\mathrm{acc}} u r(1+u) + I_{\\mathrm{acc}} u v_0$$\nWe wish to find the minimal $r$, so we solve for $r$:\n$$v_0(u(1-\\beta)-\\beta) - I_{\\mathrm{acc}} u v_0 \\le I_{\\mathrm{acc}} u r(1+u)$$\n$$v_0(u(1-\\beta)-\\beta - I_{\\mathrm{acc}}u) \\le I_{\\mathrm{acc}} u (1+u) r$$\n$$r \\ge \\frac{v_0(u(1-\\beta-I_{\\mathrm{acc}})-\\beta)}{I_{\\mathrm{acc}}u(1+u)}$$\nThis inequality defines the minimal acceptable ratio, $r_{\\min}$:\n$$r_{\\min} = \\frac{v_0(u(1-\\beta-I_{\\mathrm{acc}})-\\beta)}{I_{\\mathrm{acc}}u(1+u)}$$\nNow, substitute the numerical values:\n$u = 10$\n$v_0 = 10^4$\n$\\beta = 0.050$\n$I_{\\mathrm{acc}} = 0.050$\n$$r_{\\min} = \\frac{10^4 \\times (10(1-0.050-0.050)-0.050)}{0.050 \\times 10 \\times (1+10)}$$\n$$r_{\\min} = \\frac{10^4 \\times (10(0.90)-0.050)}{0.5 \\times 11} = \\frac{10^4 \\times (9-0.050)}{5.5} = \\frac{10^4 \\times 8.95}{5.5}$$\n$$r_{\\min} = \\frac{89500}{5.5} \\approx 16272.727...$$\nRounding to three significant figures, the minimal acceptable ratio is $1.63 \\times 10^4$.\nThis means the equilibrium dissociation constant for the interferent, $K_{d,X}$, must be at least $16300$ times larger than that for the target, $K_{d,T}$, to meet the interference specification.", "answer": "$$\\boxed{1.63 \\times 10^4}$$", "id": "5113414"}]}